1) Hoch W, McConville J, Helms S, et al : Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365-368,2001
2) Higuchi O, Hamuro J, Motomura M, et al : Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69:418-422,2011
3) Iwasa K, Kato-Motozaki Y, Furukawa Y, et al : Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis. J Neuroimmunol 225:171-174,2010
4) Casetta I, Groppo E, De Gennaro R, et al : Myasthenia gravis : a changing pattern of incidence. J Neurol 257:2015-2019,2010
5) Murai H, Yamashita N, Watanabe M, et al : Characteristics of myasthenia gravis according to onset-age : Japanese nationwide survey. J Neurol Sci 305:97-102,2011
6) Blalock A, Mason MF, Morgan HJ, et al : Myasthenia gravis and tumors of the thymic region : report of a case in which the tumor was removed. Ann Surg 110:544-561,1939
7) Le Panse R, Bismuth J, Cizeron-Clairac G, et al : Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 43:401-412,2010
8) Shiono H, Roxanis I, Zhang W, et al : Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann N Y Acad Sci 998:237-256,2003
9) Willcox N, Leite MI, Kadota Y, et al : Autoimmunizing mechanisms in thymoma and thymus. Ann N Y Acad Sci 1132:163-173,2008
10) Pal J, Rozsa C, Komoly S, et al : Clinical and biological heterogeneity of autoimmune myasthenia gravis. J Neuroimmunol 231:43-54,2011